AMRX
Amneal Pharmaceuticals Inc
Price:  
8.10 
USD
Volume:  
740,824.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Amneal WACC - Weighted Average Cost of Capital

The WACC of Amneal Pharmaceuticals Inc (AMRX) is 8.1%.

The Cost of Equity of Amneal Pharmaceuticals Inc (AMRX) is 8.90%.
The Cost of Debt of Amneal Pharmaceuticals Inc (AMRX) is 9.15%.

Range Selected
Cost of equity 7.70% - 10.10% 8.90%
Tax rate 10.50% - 23.70% 17.10%
Cost of debt 5.00% - 13.30% 9.15%
WACC 6.0% - 10.1% 8.1%
WACC

Amneal WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.82 0.93
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.70% 10.10%
Tax rate 10.50% 23.70%
Debt/Equity ratio 1.05 1.05
Cost of debt 5.00% 13.30%
After-tax WACC 6.0% 10.1%
Selected WACC 8.1%